Let Me Tell You More About My Depressed, Miserable Existence
By Depressed Jane on October 17, 2007
The House on Monday voted 382-3 to pass a bill (HR 20) that would authorize $3 million in grants in fiscal year 2008 to study the causes and treatments of postpartum depression and postpartum psychosis, CQ Today reports (Armstrong, CQ Today, 10/15).The bill, sponsored by Rep. Bobby Rush (D-Ill.), also would provide grants through [click link for full article]
Popularity: unranked [?]
By Depressed Jane on October 17, 2007
New long-term clinical trial data presented recently at the European Congress of Neuropsychopharmacology (ECNP) in Vienna showed that SEROQUEL® (quetiapine fumarate) in combination with lithium or divalproex significantly increases the time to recurrence of any mood event in patients with bipolar I disorder.1 Further pre-clinical data demonstrated that three neurotransmitter pathways are targeted by SEROQUEL in the brain – this may contribute to its unique clinical profile. [click link for full article]
Popularity: unranked [?]
By Depressed Jane on October 17, 2007
Depression has long had a popular link to cardiovascular disease and death. However, only during the last 15 years scientific evidence supporting this common wisdom has been available (Glassman et al., 2007a). Since the early 1990s studies have reported prevalences of major depression between 17% and 27% in hospitalized patients with coronary artery disease (CAD) (Rudisch & Nemeroff, 2003). [click link for full article]
Popularity: unranked [?]
By Depressed Jane on October 17, 2007
Doctors and depressed patients judge symptom severity and improvement following pharmacotherapy differently, according to data presented at the 20th Annual Meeting of the European College of Neuropsychopharmacology (ECNP) in Vienna, Austria. The data suggest physicians might not be considering symptoms that are important in the eyes of patients, such as pain and anxiety. [click link for full article]
Popularity: unranked [?]
By Depressed Jane on October 16, 2007
Valdoxan® (agomelatine), the first melatonergic antidepressant, is an effective, long-term treatment for Major Depressive Disorder (MDD) according to new data presented today at the European College of Neurospsychopharmacology (ECNP) annual congress. The new international study showed Valdoxan’s efficacy in preventing relapse in out-patients with MDD over six-months, irrespective of the severity of depression. [click link for full article]
Popularity: unranked [?]
By Depressed Jane on October 16, 2007
A new study in the October 15 issue of the Journal of Clinical Sleep Medicine (JCSM) finds that patients with obstructive sleep apnea (OSA) who also suffer from depression often find that continued use of continuous positive airway pressure (CPAP) relieves them of symptoms of depression.Daniel J. Schwartz, MD, of The Sleep Center at University’s Community Hospital in Tampa, Fla. [click link for full article]
Popularity: unranked [?]
By Depressed Jane on October 16, 2007
SPRI Clinical Trials announced that it is now screening patients for enrollment in the parAGOn Clinical Trial Program, which will start with two Phase III studies to evaluate the efficacy, safety and tolerability of agomelatine, a novel, investigational, once-daily medication for the treatment of Major Depressive Disorder (MDD). [click link for full article]
Popularity: unranked [?]
By Depressed Jane on October 13, 2007
More and more children are being diagnosed with depression. However, whether or not children should be treated with antidepressants is hotly disputed. You can read a Head to Head – where one person writes in favor, while another writes against, in this week’s issue of The British Medical Journal (BMJ). [click link for full article]
Popularity: 1% [?]
By Depressed Jane on October 12, 2007
The National Alliance on Mental Illness (NAMI) today launched its fifth annual Bipolar Disorder Awareness Day, emphasizing the need for accurate diagnosis and treatment. People diagnosed with bipolar disorder, which affects an estimated 10 million Americans, experience alternating episodes of mania (severe highs), depression (severe lows) and mixed states which contain elements of both. [click link for full article]
Popularity: unranked [?]
By Depressed Jane on October 11, 2007
Tom Wootton, author of The Bipolar Advantage, has just announced the release of his second book, The Depression Advantage, a stirring and sometimes controversial look at the depressive condition and its potential benefits for depressed people.Mr. Wootton is the founder of Bipolar Advantage: http://www.bipolaradvantage.com. [click link for full article]
Popularity: unranked [?]
